All In Biotech

Drug Trial Radar · NCT05069870

A Study to Investigate the Drug-drug Interactions (DDIs) of SKLB1028 With Itraconazole, Gemfibrozil or Rifampicin in Healthy Subjects

A Three-part, Single-center, Open-label, Phase I Drug-drug Interaction Clinical Study to Investigate the Effect of Itraconazole, Gemfibrozil or Rifampicin on Pharmacokinetics of SKLB1028 in Healthy Subjects

Last checked: Nov 19, 2026Latest source record: Oct 6, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

42

Actual

Start

Jun 7, 2021

Primary completion

Nov 2021

Study completion Nov 2021

Sponsor

Sponsor type
Industry
First posted
Oct 6, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a three-part, single-center, open-label phase I clinical study to characterize the DDIs potential of SKLB1028 with Itraconazole, Gemfibrozil or Rifampicin in healthy subjects. This study also aims to evaluate the safety and tolerability of SKLB1028 in the presence of Itraconazole, Gemfibrozil or Rifampicin.

Conditions

  • Healthy Subjects

Interventions

  • SKLB1028Drug

    SKLB1028, capsule, oral

  • ItraconazoleDrug

    Itraconazole, capsule, oral

  • GemfibrozilDrug

    Gemfibrozil, capsule, oral

  • RifampicinDrug

    Rifampicin, capsule, oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum concentration (Cmax) of SKLB1028Time frame: Up to 22 days
  2. Area under the concentration-time curve (AUC) from 0 to the last measurable concentration (AUC0-t) of SKLB1028Time frame: Up to 22 days
  3. AUC extrapolated to infinity (AUCinf) of SKLB1028Time frame: Up to 22 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Beijing Friendship Hospital, Capital Medical University

    Beijing, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.